Xylem (NYSE:XYL) Price Target Raised to $142.00 at Oppenheimer

Xylem (NYSE:XYL) had its price objective hoisted by investment analysts at Oppenheimer from $133.00 to $142.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the industrial products company’s stock. Oppenheimer’s price objective would suggest a potential upside of 11.36% from the stock’s current price.

Several other equities analysts have also recently issued reports on XYL. Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Robert W. Baird lifted their price objective on shares of Xylem from $141.00 to $148.00 and gave the stock an “outperform” rating in a research note on Thursday, March 21st. BNP Paribas started coverage on shares of Xylem in a report on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 target price for the company. Citigroup raised their target price on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a report on Monday, April 8th. Finally, Stifel Nicolaus raised their target price on shares of Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a report on Wednesday, February 7th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, Xylem has a consensus rating of “Moderate Buy” and a consensus target price of $138.11.

Xylem Price Performance

Shares of XYL traded up $1.30 during mid-day trading on Thursday, hitting $127.52. The company’s stock had a trading volume of 82,269 shares, compared to its average volume of 1,133,307. The firm has a 50-day moving average price of $126.85 and a 200 day moving average price of $112.01. The stock has a market capitalization of $30.91 billion, a price-to-earnings ratio of 46.78, a PEG ratio of 2.55 and a beta of 1.10. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.30. Xylem has a fifty-two week low of $87.59 and a fifty-two week high of $130.86.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.03. The company had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.05 billion. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The business’s revenue was up 40.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.92 EPS. On average, research analysts predict that Xylem will post 4.13 EPS for the current fiscal year.

Insider Buying and Selling

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the sale, the chief accounting officer now directly owns 2,935 shares in the company, valued at $360,682.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the transaction, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by corporate insiders.

Institutional Trading of Xylem

A number of institutional investors have recently bought and sold shares of XYL. Bruce G. Allen Investments LLC bought a new position in shares of Xylem during the fourth quarter worth $27,000. NBC Securities Inc. bought a new stake in Xylem in the 3rd quarter valued at $38,000. KB Financial Partners LLC bought a new stake in Xylem in the 1st quarter valued at $42,000. Coppell Advisory Solutions LLC bought a new stake in Xylem in the 2nd quarter valued at $45,000. Finally, Orion Capital Management LLC bought a new stake in Xylem in the 3rd quarter valued at $48,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.